Skip to main content
. 2017 Apr 12;18(4):817. doi: 10.3390/ijms18040817

Figure 2.

Figure 2

Zebrafish embryo length is affected by triadimefon exposure. (A–C) Examples of measurements of embryo length from 0.1% DMSO control (A), 2 and 4 μg/mL triadimefon (B,C respectively) at 120 hpf. Embryos shown to the same scale, indicated by the scale bar (=500 µm in C). (D) Bar chart illustrates average body length in 0.1% DMSO controls, 2 and 4 μg/mL triadimefon treated embryos, at 120 hpf. Body lengths of triadimefon treated embryos decreased in a dose-dependent manner. The highest triadimefon concentration exposure leads to a statistically significant length reduction of 4 μg/mL triadimefon exposed embryos as compared to the control group. The number of embryos examined in the control, 2 and 4 μg/mL triadimefon concentration groups were 45, 31 and 36 respectively. Asterisk(s) denote statistical significance; ** p ≤ 0.01. FON, triadimefon. Error bars indicate standard deviations.